SCHEMBL2076153

SCHEMBL2076153

COC(=O)c1cc2c([nH]1)C(Cc1cccc(Cl)c1)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
CNR2 P34972 1/20 0.43
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP12 P39900 1/20 0.41
SLC6A3 Q01959 4/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
IDE P14735 1/20 0.41
ACHE P22303 2/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
APEX1 P27695 1/20 0.39
PAX8 Q06710 1/20 0.39
EPHX2 P34913 1/20 0.38
CDKN1A P38936 1/20 0.37
SLC6A2 P23975 1/20 0.37
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003759 0.88 ESR1 (0.51) GAAESR1ESR2CDKN1A
SCHEMBL1005081 0.88 CNR2 (0.44) CNR2MMP1MMP2MMP9MMP12
SCHEMBL1004115 0.87 MMP2 (0.41) POLBMMP1MMP2MMP9MMP12
SCHEMBL1003764 0.87 MMP1 (0.45) MMP1MMP2MMP9MMP12KMT2A
SCHEMBL1004644 0.84 METAP2 (0.35) POLBGAAKMT2AMEN1IDE
SCHEMBL1005522 0.83 POLB (0.42) POLBGAACNR2MMP1MMP2
SCHEMBL1006816 0.80 SLC6A3 (0.44) POLBGAASLC6A3KMT2AMEN1
SCHEMBL1004272 0.78 PPARD (0.44) MMP1MMP2MMP9MMP12APEX1
SCHEMBL1005338 0.77 RAB9A (0.44) GAASLC6A3KMT2AMEN1ACHE
SCHEMBL1004646 0.75 HCAR2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE POLB 997/4885GAA 309/4885CNR2 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.